Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : The New Qualcomm - a S&P500 company -- Ignore unavailable to you. Want to Upgrade?

To: Maurice Winn who wrote (363)	7/29/1999 9:18:00 AM
From: HairBall	Respond to of 13582

I have posted both a linear and semi-log chart on my chart page on the MDA Web Site at: homestead.com Below is my reply regarding QCOM. beta.siliconinvestor.com Regards, LG

To: Maurice Winn who wrote (363)	7/29/1999 11:13:00 AM
From: Eric L	Respond to of 13582

Maurice, << I say VW40 is vapour wear, not will be. It is quite possible Ericy and others will cobble together something they'll call W-CDMA which will work. >> VW40 is good for now (since you and others were kind enough to explain what it is <g>). I am assuming that by VW40 you are including ETSI UTRA, and ARIB W-CDMA and perhaps WP-CDMA (USA), CDMA I / CDMA II (TTA). Are you also including TIA cdma2000 as VW40, or is that exempt? Until the harmonization and convergence of IMT-2000 proposals is complete I consider all of the above to be VW40. I think we can assume (I do) that ETSI UTRA (the air interface for ETSI UMTS) will work, just as many of us thought that CDMA would work before it was commercially launched. The good news is that Qualcomm will receive royalties on implementations of UTRA from a source they do not currently receive them (GSM Networks), even if subscribers are counted as GSM/UMTS/UTRA rather than CDMA subscribers. As the UMTS Forum would say ("UMTS builds on today's significant investments in GSM mobile systems ... UMTS has the support of hundreds of network operators, manufacturers and equipment vendors worldwide"). The specification has been in the works in draft form since early 1997 and is due to be published as a Phase 1 specification in January. 3GIG pulled last years revised draft specifications from the GSM MoU sight several months ago and they will be replaced hopefully by the real thing on or before 12/31. I am hopeful that the CDG site will shortly post something more current than the November 1998 3G whitepaper. If there is something more current I'd appreciate the link an thanks for the "Divergent" link you supplied in your response to my question asking what VW40 was. - Eric -

To: Maurice Winn who wrote (363)	8/2/1999 10:32:00 AM
From: DaveMG	Respond to of 13582

OT for most but not of course for MqDNAurice Clinical Micro Sensors Announces Alliance with Motorola to Advance Emerging Field of Biochip Technology Investment by Motorola in CMS Marks Companies' Commitment to Revolutionizing The Practical Uses of Molecular Research PASADENA, Calif., August 2 /PRNewswire/ -- Clinical Micro Sensors Inc. (CMS) today announced that it has entered into a multi-year strategic alliance with Motorola (NYSE: MOT - news) to further advance developments in electronics and biochip technology. The relationship includes an initial equity investment by Motorola with the option to invest additional funds in future financing of CMS. To date, CMS has raised a total of $23 million from private and corporate investors. The relationship is intended to explore ways in which the latest developments in molecular research and distributed electronics could be used to detect and treat disease, manage the food supply and protect the environment. Potential products could have an impact on a broad range of markets, including clinical and industrial diagnostics, biomedical research, pharmacogenomics, agriculture, the environment and the military. ''We believe that Motorola is an ideal partner to help CMS expand the market for our portable DNA sensor technology,'' said Jon Kayyem, President and CEO of CMS. ''Motorola's strengths in the design and fabrication of electronic devices, as well as its chip manufacturing capabilities, will help to make the analysis of DNA and other complex biological molecules both routine and cost-effective.'' CMS has developed a patented technology for detecting and analyzing DNA and other biomolecules. This detection technology is unique among the methods available for detecting DNA and other biological molecules because it uses low-cost, durable biochips, is simple to use, and produces electronic results. CMS' technology is complementary to Motorola's plans to penetrate the biotechnology industry. Motorola is known for its strengths in electronics, communications, portable devices and integrated systems, and has been developing biochip-based systems for application in a variety of markets. ''CMS has a unique and exciting technology which will enable portable DNA diagnostics across a variety of applications,'' said Nicholas Naclerio, Vice President and General Manager of Motorola BioChip Systems. ''We share a vision of the potential for DNA diagnostics to improve the quality of life. We are impressed with the company, its management team and its progress.'' ''Motorola has a history of pioneering new industries. Our BioChip Systems unit is applying our strengths in engineering and high quality manufacturing to enable new products for the Life Sciences arena,'' said Rud Istvan, Motorola Senior Vice President and Director of Corporate Strategy. ''Partnerships such as that with CMS are part of our approach to establish a leadership position in this industry.'' Clinical Micro Sensors, Inc. was founded in 1995 to expand the range of applications for microchip-based analysis of DNA and other biomolecules. Its detection technology promises to expand the range of commercial uses for molecular diagnostics. Applications include clinical and industrial diagnostics, biomedical research, pharmacogenomics, agriculture, and the detection of pathogens in food, the environment, and for military purposes. CMS, located in Pasadena, Calif., is privately held. The company's web site is microsensor.com . Motorola is a global leader in providing integrated communications solutions and embedded electronic solutions. These include: software-enhanced wireless telephone, two-way radio, messaging and satellite communications products and systems, as well as networking and Internet-access products, for consumers, network operators, and commercial, government and industrial customers; embedded semiconductor solutions for customers in the consumer, networking and computing, transportation and wireless communications markets; and embedded electronic systems for automotive, communications, imaging, manufacturing systems, computer and consumer markets. Sales in 1998 were $29.4 billion. Visit Motorola at motorola.com . SOURCE: Clinical Micro Sensors Inc.